Related Experiment Video
Updated: May 28, 2025
12:59
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
12.5K
[How to manage type 2 diabetes in the elderly]
1Service d'Endocrinologie, Diabétologie et Nutrition, CHC MontLégia, Liège, Belgique.
Revue Medicale De Liege
|February 14, 2025
Summary
Managing type 2 diabetes in older adults requires individualized glycaemic targets, prioritizing quality of life and avoiding hypoglycemia. Therapy must consider patient frailty, comorbidities like cardiovascular disease, and life expectancy for optimal outcomes.
Area of Science:
- Gerontology
- Endocrinology
- Pharmacology
Context:
- Type 2 diabetes mellitus (T2DM) management in older adults presents unique challenges.
- Aging populations necessitate tailored approaches to chronic disease care.
- Geriatric syndromes and patient frailty significantly impact treatment decisions.
Purpose:
- To outline adapted glycaemic objectives for elderly patients with T2DM.
- To emphasize the importance of personalized therapeutic strategies in geriatric diabetes care.
- To highlight key considerations for drug selection in older patients with T2DM.
Summary:
- Glycaemic targets for T2DM in older adults should be individualized based on health status (vigorous, fragile, ill) and life expectancy.
- Therapeutic basics for T2DM are similar to younger patients, but avoiding hypoglycemia is paramount.
- Comorbidities such as cardiovascular disease, heart failure, and chronic kidney disease influence medication choices.
Impact:
- Facilitates safer and more effective T2DM management in the elderly population.
- Promotes a patient-centered approach, enhancing quality of life.
- Provides guidance for clinicians on adapting T2DM therapy for older individuals.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
229
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
229
01:22Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
01:36Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
01:15Diabetes: Symptoms, Diagnosis, and Complications
498
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
498
01:16Insulin: Dosing Regimen and Adverse Effects
139
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
139